These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 3799625)
1. ASHP statement on the pharmacy and therapeutics committee. Am J Hosp Pharm; 1986 Nov; 43(11):2841-2. PubMed ID: 3799625 [No Abstract] [Full Text] [Related]
2. ASHP statement on the pharmacy and therapeutics committee. Am J Hosp Pharm; 1992 Aug; 49(8):2008-9. PubMed ID: 1442847 [No Abstract] [Full Text] [Related]
3. ASHP statement on the pharmacy and therapeutics committee. Am J Hosp Pharm; 1978 Jul; 35(7):813-4. PubMed ID: 665701 [No Abstract] [Full Text] [Related]
4. ASHP guidelines on formulary system management. Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948 [No Abstract] [Full Text] [Related]
5. Editorial: The ASHP council on clinical pharmacy and therapeutics. Zellmer WA Am J Hosp Pharm; 1974 Sep; 31(9):831. PubMed ID: 4423139 [No Abstract] [Full Text] [Related]
6. ASHP statement on hospital drug control systems. Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439 [No Abstract] [Full Text] [Related]
7. ASHP technical assistance bulletin on assessing cost-containment strategies for institutional pharmacies. Am J Hosp Pharm; 1985 Jul; 42(7):1583-91. PubMed ID: 4025363 [No Abstract] [Full Text] [Related]
8. Improving pharmacy and therapeutics committee operations. Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511 [TBL] [Abstract][Full Text] [Related]
9. Promoting rational drug use through the ASHP Commission on Therapeutics. Witmer DR Am J Hosp Pharm; 1994 Jun; 51(12):1536. PubMed ID: 8092154 [No Abstract] [Full Text] [Related]
10. Contemporary challenges and novel strategies for health-system formulary management. Heindel GA; McIntyre CM Am J Health Syst Pharm; 2018 Apr; 75(8):556-560. PubMed ID: 29626005 [No Abstract] [Full Text] [Related]
11. The Pharmacy and Therapeutics Committee Part 1: overview. Bender FH Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199 [TBL] [Abstract][Full Text] [Related]
12. Philosophy and practice of the P & T Committee. Lipman AG Hosp Formul; 1983 Jun; 18(6):599. PubMed ID: 10260200 [No Abstract] [Full Text] [Related]
13. Managing the P & T Committee agenda. Lipman AG Hosp Formul; 1987 Apr; 22(4):331. PubMed ID: 10281366 [No Abstract] [Full Text] [Related]
14. The JCAH and the P&T Committee. Lipman AG Hosp Formul; 1985 Mar; 20(3):263. PubMed ID: 10289613 [No Abstract] [Full Text] [Related]
15. An American in a Parisian P&T committee. Weintraub M Hosp Formul; 1981 Nov; 16(11):1311-3, 1316. PubMed ID: 10253177 [No Abstract] [Full Text] [Related]
16. The P&T Society. Bootman L Manag Care Interface; 2006 Feb; 19(2):13, 15. PubMed ID: 16583504 [No Abstract] [Full Text] [Related]
17. Subcommittees: Balkanization of the P & T committee? Weintraub M Hosp Formul; 1985 Sep; 20(9):947. PubMed ID: 10274167 [No Abstract] [Full Text] [Related]
19. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Tyler LS; Cole SW; May JR; Millares M; Valentino MA; Vermeulen LC; Wilson AL; Am J Health Syst Pharm; 2008 Jul; 65(13):1272-83. PubMed ID: 18589893 [No Abstract] [Full Text] [Related]
20. ASHP long-range position statement on pharmacy manpower needs and residency training. Am J Hosp Pharm; 1980 Sep; 37(9):1220. PubMed ID: 7416178 [No Abstract] [Full Text] [Related] [Next] [New Search]